Prospective study of vaginal bacterial flora and other risk factors for vulvovaginal candidiasis.
about
Interventions for prevention and treatment of vulvovaginal candidiasis in women with HIV infectionIL-17-Mediated Immunity to the Opportunistic Fungal Pathogen Candida albicansRecombinant Human IFNα-2b Response Promotes Vaginal Epithelial Cells Defense against Candida albicans.Prospective study of correlates of vaginal Lactobacillus colonisation among high-risk HIV-1 seronegative women.Candida infections of the genitourinary tract.Host responses to Candida albicans: Th17 cells and mucosal candidiasis.The epidemiology, pathogenesis, and diagnosis of vulvovaginal candidosis: a mycological perspective.Diverse vaginal microbiomes in reproductive-age women with vulvovaginal candidiasis.Effect of norfloxacin therapy for acute, uncomplicated lower urinary tract infection on vaginal Candida prevalence.Candida albicans Pathogenesis: Fitting within the Host-Microbe Damage Response Framework.Epidemiologic features of Vulvovaginal Candidiasis among reproductive-age women in IndiaThe vaginal mycobiome: A contemporary perspective on fungi in women's health and diseasesDoes removal of CU-IUD in patients with biofilm forming candida really maintain regression of clinical symptoms?Growth of Candida albicans cells on the physiologically relevant carbon source lactate affects their recognition and phagocytosis by immune cells.Is antibiotic prophylaxis necessary before midurethral sling procedures for female stress incontinence? A decision analysis.Mixed vaginitis-more than coinfection and with therapeutic implications.A novel mechanism behind the immunopathogenesis of vulvovaginal candidiasis: "Neutrophil Anergy".Incidence of unintended pregnancy among female sex workers in low-income and middle-income countries: a systematic review and meta-analysis
P2860
Q24234875-AB05DEA2-A9B7-4B3C-8D0B-EE97F2972328Q26799351-DB7B22D0-BD87-4370-9C00-718BD43341C0Q33580895-35B6868B-5F82-4903-8E03-67EA12A6EE50Q33723224-70A49C83-630D-4264-9E8B-EF704D34B99BQ33825621-35E0982E-0B08-432C-8A9E-B1054D6D7643Q33941537-DFE76D6D-8BFF-4CBA-A9BC-83789966C9F9Q34186380-B9D2A32A-EC1F-4CD2-8BBF-FE1A8D822D68Q35050537-426D0D24-60BB-40C9-AB94-3042697B2A94Q35840387-15D58EC1-36BA-41DD-A6C5-BEF829581664Q36080619-B06F69F3-0F16-4040-B9D2-01DC8636D632Q36340226-76E80373-ADC7-4E78-852D-1D411340C7F6Q40531004-46B47071-2B7E-4BD7-9818-A1A4B2BCE95FQ41605423-2F6E5C4D-2C8B-4130-BF7C-D0A3CD799E48Q42250880-42EE5500-B913-4A3B-AEBE-ECCDC2A869F6Q42253009-EEA78147-E201-45EA-84E2-FFFE523251D1Q42277369-9A38BD09-681C-4547-9272-452026EFD4AEQ50083006-D6E9EA4C-6092-484E-909C-9FB6DA5CB11FQ58732380-90D60816-896C-4610-BBF6-9A52C0A7F298
P2860
Prospective study of vaginal bacterial flora and other risk factors for vulvovaginal candidiasis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Prospective study of vaginal b ...... for vulvovaginal candidiasis.
@en
Prospective study of vaginal b ...... for vulvovaginal candidiasis.
@nl
type
label
Prospective study of vaginal b ...... for vulvovaginal candidiasis.
@en
Prospective study of vaginal b ...... for vulvovaginal candidiasis.
@nl
prefLabel
Prospective study of vaginal b ...... for vulvovaginal candidiasis.
@en
Prospective study of vaginal b ...... for vulvovaginal candidiasis.
@nl
P2093
P2860
P356
P1476
Prospective study of vaginal b ...... for vulvovaginal candidiasis.
@en
P2093
Barbra A Richardson
James Kiarie
Jared M Baeten
Jeckoniah O Ndinya-Achola
King K Holmes
Kishorchandra Mandaliya
R Scott McClelland
Wisal M Hassan
P2860
P304
P356
10.1086/599213
P407
P577
2009-06-01T00:00:00Z